22 related articles for article (PubMed ID: 22954144)
1. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT.
Ding YS; Singhal T; Planeta-Wilson B; Gallezot JD; Nabulsi N; Labaree D; Ropchan J; Henry S; Williams W; Carson RE; Neumeister A; Malison RT
Synapse; 2010 Jan; 64(1):30-8. PubMed ID: 19728366
[TBL] [Abstract][Full Text] [Related]
2. Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus.
Pietrzak RH; Gallezot JD; Ding YS; Henry S; Potenza MN; Southwick SM; Krystal JH; Carson RE; Neumeister A
JAMA Psychiatry; 2013 Nov; 70(11):1199-1205. PubMed ID: 24048210
[TBL] [Abstract][Full Text] [Related]
3. Relationships of in vivo brain norepinephrine transporter and age, BMI, and gender.
Koohsari S; Sadabad FE; Pittman B; Gallezot JD; Carson RE; van Dyck CH; Li CR; Potenza MN; Matuskey D
Synapse; 2023 Sep; 77(5):e22279. PubMed ID: 37382240
[TBL] [Abstract][Full Text] [Related]
4. A Positron Emission Tomography Study of Norepinephrine Transporter Occupancy and Its Correlation with Symptom Response in Depressed Patients Treated with Quetiapine XR.
Yatham LN; Sossi V; Ding YS; Vafai N; Arumugham SS; Dhanoa T; Lam RW; Bond DJ; Puyat JH
Int J Neuropsychopharmacol; 2018 Feb; 21(2):108-113. PubMed ID: 29016993
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart.
Kiyono Y; Sugita T; Ueda M; Kawashima H; Kanegawa N; Kuge Y; Fujibayashi Y; Saji H
Nucl Med Biol; 2008 Feb; 35(2):213-8. PubMed ID: 18312831
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of radioiodinated (S,S)-2-(alpha-(2-iodophenoxy)benzyl)morpholine for imaging brain norepinephrine transporter.
Kanegawa N; Kiyono Y; Kimura H; Sugita T; Kajiyama S; Kawashima H; Ueda M; Kuge Y; Saji H
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):639-47. PubMed ID: 16523308
[TBL] [Abstract][Full Text] [Related]
7. The norepinephrine transporter (NET) radioligand (S,S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer's disease: a post-mortem autoradiographic study.
Gulyás B; Brockschnieder D; Nag S; Pavlova E; Kása P; Beliczai Z; Légrádi A; Gulya K; Thiele A; Dyrks T; Halldin C
Neurochem Int; 2010; 56(6-7):789-98. PubMed ID: 20211213
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine as a ligand for brain norepinephrine transporter imaging.
Kiyono Y; Kanegawa N; Kawashima H; Kitamura Y; Iida Y; Saji H
Nucl Med Biol; 2004 Feb; 31(2):147-53. PubMed ID: 15013479
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine transporter imaging in the brain of a rat model of depression using radioiodinated (2S, αS)-2-(α-(2-iodophenoxy)benzyl)morpholine.
Kanegawa N; Kiyono Y; Sugitaa T; Kuge Y; Fujibayasi Y; Saji H
Mol Imaging; 2012; 11(4):280-5. PubMed ID: 22954144
[TBL] [Abstract][Full Text] [Related]
10. Imaging the Future of Major Depression.
Dunlop BW
Focus (Am Psychiatr Publ); 2018 Oct; 16(4):3s. PubMed ID: 31975940
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
